[1]
“MOLECULAR GENETIC MARKERS FOR DIAGNOSING METACHRONOUS ONCOGYNECOLOGICAL TUMORS IN BREAST CANCER PATIENTS”, WEJMMS, vol. 4, no. 01, pp. 10–18, Jan. 2026, Accessed: Jan. 31, 2026. [Online]. Available: https://westerneuropeanstudies.com/index.php/3/article/view/3206